Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients
2019
COVID-19: A global transplant perspective on successfully navigating a pandemic
2020
Brain Abscess in Solid Organ Transplant Recipients Receiving Cyclosporine-Based Immunosuppression
1997
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
2003
Liver transplantation in children
2006
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Increasing Incidence of Adenovirus Disease in Bone Marrow Transplant Recipients
1994
Clinical Aspects of Fungal Infection in Organ Transplant Recipients
1994
Immunosuppressive Drugs in Paediatric Liver Transplantation
2001
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Cystic fibrosis
2016 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation
2015
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
2013
Vaccination in Solid Organ Transplantation
2013
Viral Infection in the Renal Transplant Recipient
2005
Cytomegalovirus Infection After Intestinal Transplantation in Children
1997
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients
2011
Microbial synthesis of poly(ε-lysine) and its various applications
2004 Standout
Tacrolimus
1993
Respiratory virus shedding in exhaled breath and efficacy of face masks
2020 Standout
PARVOVIRUS B19 INFECTION IN PEDIATRIC TRANSPLANT PATIENTS
1993
Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
1999 StandoutNobel
Invasive Aspergillosis in Transplant Recipients
1999
Outcome, Incidence, and Timing of Infectious Complications in Small Bowel and Multivisceral Organ Transplantation Patients
2005
Emerging Infections: Adenovirus Infections in Transplant Recipients
2006
Antivirals and resistance: influenza virus
2011
Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel
1999
Infections in Liver Transplant Recipients
1995
Impact of Immunosuppression on Recall Immune Responses to Influenza Vaccination in Stable Renal Transplant Recipients
2013
Nocardiosis at the Turn of the Century
2009 Standout
Echinocandin antifungal drugs
2003 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery
2005
Monitoring of Epstein‐Barr virus load after hematopoietic stem cell transplantation for early intervention in post‐transplant lymphoproliferative disease
2008
Clinical Pharmacokinetics of Tacrolimus
1995 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Delayed-Onset Cytomegalovirus Disease Coded During Hospital Readmission After Kidney Transplantation
2014
Characterization of Human Proliferative T Cell Responses to Adenovirus
1995
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
Infectious complications in pediatric solid organ transplantation
2003
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Assessment of Cytomegalovirus Hybrid Preventative Strategy in Pediatric Heart Transplant Patients
2012
Replacement of donor lymphoid tissue in small-bowel transplants
1991
The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report—2017; Focus Theme: Allograft ischemic time
2017 Standout
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation
2016
Cytomegalovirus in Solid Organ Transplantation
2013
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
1998
Infection in Solid-Organ Transplant Recipients
2007 Standout
A Hybrid Strategy for the Prevention of Cytomegalovirus-Related Complications in Pediatric Liver Transplantation Recipients
2009
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
2020 Standout
Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial
2012
Viral infections in immunocompromised patients: whatʼs new with respiratory viruses?
2002
Influenza vaccination in solid-organ transplant recipients
2012
Cytomegalovirus in Solid Organ Transplant Recipients
2009
Infection in Organ-Transplant Recipients
1998 Standout
Randomized Controlled Trial of High-Dose Intradermal Versus Standard-Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients
2013
Cell migration, chimerism, and graft acceptance
1992 Standout
The invasive and saprophytic syndromes due toAspergillusspp.
2005
Epstein–Barr Virus Infection
2000 Standout
Zoonotic Potential and Molecular Epidemiology ofGiardiaSpecies and Giardiasis
2011 Standout
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients
2017
Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
2014
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients
2011
Infectious complications after small bowel transplantation in adults: an update.
1996
Zygomycetes in Human Disease
2000 Standout
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update
2016
Infections in solid-organ transplant recipients
1997
Prevention and Control of Seasonal Influenza with Vaccines
2016
Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances
2008
Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression
1993
Human Parvovirus B19
2002 Standout
First Reported Outbreak of Diarrhea Due to Adenovirus Infection in a Hematology Unit for Adults
2005
Current and Emerging Azole Antifungal Agents
1999 Standout
Antibody response to the non‐adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients
2012
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
1991
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The many faces of multivisceral transplantation.
1991
Invasive Central Nervous System Aspergillosis
1995
Brain Abscess Following Marrow Transplantation: Experience at the Fred Hutchinson Cancer Research Center, 1984-1992
1994
Aspergillus fumigatusand Aspergillosis
1999 Standout
Inhibition of Virus Multiplication by Foreign Nucleic Acid
1963 Nature
Two-year experience with FK 506 in pediatric patients.
1993
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services
2020 Standout
Biological Properties of Poly-α- Amino Acids
1959
CRYPTOSPORIDIOSIS AND OTHER INTESTINAL PROTOZOAN INFECTIONS IN CHILDREN LESS THAN ONE YEAR OF AGE IN MEXICO CITY
2006
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Changing Face of Vaccination in Immunocompromised Hosts
2014
Guidelines for Treatment of Candidiasis
2004 Standout
Neurologic complications of FK 506.
1991
Hidden Killers: Human Fungal Infections
2012 Standout
Comparison of Intravenous Ganciclovir Followed by Oral Acyclovir with Intravenous Ganciclovir Alone for Prevention of Cytomegalovirus and Epstein‐Barr Virus Disease After Liver Transplantation in Children
1997
Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel
1999
Invasive Central Nervous System Aspergillosis
1995
High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence
2016
Works of M. Green being referenced
CMV-IVIG for Prevention of Epstein Barr Virus Disease and Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipients
2006
Epstein–Barr virus load monitoring: its role in the prevention and management of post‐transplant lymphoproliferative disease
2001
Cryptosporidial infections after solid organ transplantation in children
2000
Guidance on Novel Influenza A/H1N1 in Solid Organ Transplant Recipients
2009
Aspergillosis of the CNS in a Pediatric Liver Transplant Recipient: Case Report and Review
1991
Considerations for Screening Live Kidney Donors for Endemic Infections: A Viewpoint on the UNOS Policy
2014
Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations
2011
Adenovirus Infection in Pediatric Liver Transplant Recipients
1992
Infectious complications after human small bowel transplantation.
1992
Protection of Embryonated Eggs Infected with Infectious Bronchitis or Newcastle Disease Virus by Polypeptides.
1953
Factors associated with recurrent cytomegalovirus disease after small bowel transplantation.
1994
Use of FK 506 in pediatric patients.
1991
Infectious complications of pediatric liver transplantation under FK 506.
1991
Introduction: Infections in Solid Organ Transplantation
2013
Cytomegalovirus disease in intestinal transplantation.
1995
FK 506 versus cyclosporine in pediatric liver transplantation.
1991
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.
1991